Samriddhiprogressive Pharma Private Limited
About Samriddhiprogressive Pharma Private Limited
Data last updated:
Samriddhiprogressive Pharma Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 06 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74120UP2015PTC071852. Its GSTIN is 09AAWCS0681E1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Sunil Kumar Srivastava and Rachna Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at G – 59A Phase – 11 Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, India – 226012.
As per the financials filed for FY 2022, the company reported a revenue of ₹74.25 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹2,157 (net margin 0%) and EBITDA of ₹7.04 Lakh (EBITDA margin 9.5%). Revenue has declined at a compounded annual rate (CAGR) of 26% over three years and 19% over five years.
As per MCA filings, the company has open charges of ₹40 Lakh on record. Court records list 31 cases involving the company, including 29 filed by the company and 2 filed against it; 13 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Samriddhiprogressive Pharma Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressG – 59A Phase – 11 Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, India – 226012
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Samriddhiprogressive Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Samriddhiprogressive Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Samriddhiprogressive Pharma Private Limited, buy the company report.
Financials of Samriddhiprogressive Pharma Private Limited
FY 2023 filings availableSamriddhiprogressive Pharma Private Limited reported revenue of ₹74.25 Lakh (down 10% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 10% fall in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.04 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,157 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.5% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Samriddhiprogressive Pharma Private Limited, buy the company report.
Board of directors of Samriddhiprogressive Pharma Private Limited
Samriddhiprogressive Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Kumar Srivastava | Director | 07 Jun 2024 | 2 Years 4 Months | Current |
| Rachna Srivastava Also directs: Ramayani Fincare Private Limited | Director | 06 Jul 2015 | 11 Years 3 Months | Current |
| Tapan Kumar Mukherjee | Director | 23 Apr 2019 | 7 Years 5 Months | Current |
Peer comparison
Samriddhiprogressive Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Orgyne Pharmaceuticals (OPC) Private Limited | ₹74.94 Lakh (FY 2024) | 13.0% | Hyderabad, Telangana, India | |||
| Acevision Chemicals Private Limited | ₹74.44 Lakh (FY 2025) | 397.0% | Kanpur, Uttar Pradesh, India | |||
| Samriddhiprogressive Pharma Private Limitedthis company | ₹74.25 Lakh (FY 2022) | ₹2,157 | 0% | -10.0% | Lucknow, Uttar Pradesh, India | |
| Shibling Coating and Chemicals (OPC) Private Limited | ₹74.14 Lakh (FY 2025) | -14.0% | Ghola, West Bengal, India | |||
| Sears Phytochem Private Limited | ₹74.07 Lakh (FY 2025) | -12.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Samriddhiprogressive Pharma Private Limited, buy the company report.
Auditor
Samriddhiprogressive Pharma Private Limited is audited by R S J B & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R S J B & ASSOCIATES | FY 2018 | 018712C |
Shareholding
The shareholding of Samriddhiprogressive Pharma Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Samriddhiprogressive Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Oct 2018 | 100223360 | Others | ₹40 Lakh | Open |
To see the full charge records of Samriddhiprogressive Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Samriddhiprogressive Pharma Private Limited has 31 court cases on record: 29 filed by Samriddhiprogressive Pharma, 2 filed against it. 13 cases are pending and 18 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 31 | 2 | 13 |
Cases on record (5 of 31)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Cheque dishonour complaint | Filed against the company by Medi Access Solutions Pvt Ltd | Disposed |
| District court, West, Delhi | Cheque dishonour complaint | Filed against the company by Medi Access Solutions Pvt | Pending |
| District court, Lucknow, Uttar Pradesh | Criminal case | Filed by the company against M/S Deo Medical Agency THR Deepak Sharma | Pending |
| District court, Lucknow, Uttar Pradesh | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Lucknow, Uttar Pradesh | Cheque dishonour complaint | Filed by the company against Janak Pharmaceuticals THR. Ajay Kumar | Pending |
To see the full case history of Samriddhiprogressive Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Samriddhiprogressive Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Samriddhiprogressive Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAWCS0681E1ZX | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Samriddhiprogressive Pharma Private Limited, buy the company report.
Recent activity
Samriddhiprogressive Pharma Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Rolly Srivastava ceased to be Director on 07 Jun 2024.
Frequently asked questions
Samriddhiprogressive Pharma is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 06 July 2015 (11+ years old) and is registered under CIN U74120UP2015PTC071852.
Samriddhiprogressive Pharma has 3 current directors:
- Sunil Kumar Srivastava - Director
- Rachna Srivastava - Director
- Tapan Kumar Mukherjee - Director
The latest financial statements of Samriddhiprogressive Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Samriddhiprogressive Pharma is 09AAWCS0681E1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Samriddhiprogressive Pharma is U74120UP2015PTC071852. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Samriddhiprogressive Pharma has 31 court cases on record: 29 filed by the company and 2 filed against it. 13 are pending.
Samriddhiprogressive Pharma was incorporated on 06 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Samriddhiprogressive Pharma by revenue are Orgyne Pharmaceuticals (OPC) Private Limited, Acevision Chemicals Private Limited, Shibling Coating and Chemicals (OPC) Private Limited, Sears Phytochem Private Limited, all in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rolly Srivastava ceased to be Director on 07 Jun 2024. Sunil Kumar Srivastava was appointed as Director on 07 Jun 2024. Tapan Kumar Mukherjee was appointed as Director on 23 Apr 2019. Samriddhiprogressive Pharma has 4 board changes on record in total.
The registered office of Samriddhiprogressive Pharma is at G – 59A Phase – 11 Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, India – 226012.
Samriddhiprogressive Pharma operates in the chemicals and materials industry, in the industrial chemicals segment.